Compare Summit Therapeutics Inc (SMMT) vs VNET Group Inc (VNET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs VNET Group Inc — how do they compare? Summit Therapeutics Inc trades at $14.58 (market cap $10.48B), while VNET Group Inc trades at $7.7 (market cap $2.19B). The key difference: Summit Therapeutics Inc is far larger — about 4.8× VNET Group Inc's market cap. Which is the better fit depends on your goals.
| SMMT | VNET | |
|---|---|---|
Market Cap | $10.48B | $2.19B |
Sector | Health | Technology |
52-Week High | $29.32 | $14.03 |
52-Week Low | $13.05 | $7.34 |
Enterprise Value | $9.90B | $5.32B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About VNET Group Inc
VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →
